首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1922659

日本免疫組織化學市場報告：按產品、應用、最終用戶和地區分類（2026-2034年）

Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本免疫組織化學市場規模達1.885億美元。 IMARC Group預測，到2034年，該市場規模將達到3.226億美元，2026年至2034年的複合年成長率（CAGR）為6.15%。推動市場成長的關鍵因素包括：與老齡化相關的疾病增加、完善的醫療基礎設施、個人化醫療意識的提高、政府對醫學研究投入和支持的增加，以及病理學領域的最新進展。

免疫組織化學 (IHC) 是一種診斷和研究技術，它利用抗原-抗體相互作用的原理來識別組織樣本中的特定蛋白質、抗原或細胞。將抗體應用於含有組織切片的玻片上，抗體與目標抗原反應，然後使用顯色或螢光染料進行可視化。免疫組織化學有多種類型，包括顯色法、螢光和多重法。該技術涉及多個組分，包括一抗和二抗、檢測系統和基材。 IHC 具有許多優勢，例如高特異性、高靈敏度和能夠精確定位細胞組成。它廣泛應用於腫瘤學、神經生物學、感染疾病和組織形態發生學等領域。此外，它也應用於法醫學、環境研究和藥物檢測。 IHC 具有成本效益高、速度快、能夠處理大量檢體等優點。此外，免疫組織化學也以其微創性、原位分析、定量能力以及與自動化技術無縫整合進行高通量篩檢等特性而聞名。

日本免疫組織化學市場趨勢：

日本老齡化相關疾病（如阿茲海默症和癌症）的日益增多，推動了對免疫組織化學檢測的需求，進而促進了市場成長。此外，完善的醫療基礎設施為免疫組織化學（IHC）等複雜診斷技術的應用提供了支持，也推動了市場成長。個人化醫療意識的不斷提高，也帶動了對標靶診斷技術的需求，進一步促進了市場成長。政府對醫學研究的投入和支持不斷增加，也推動了市場成長。此外，需要早期準確診斷的文明病發病率的上升，也對市場成長產生了積極影響。病理學領域的最新進展，尤其是在組織診斷方面，提升了IHC的重要性，也推動了市場成長。同時，產學研合作的加強，促進了IHC的研發，也推動了市場成長。因此，日本IHC流程自動化程度的提高，減少了人為誤差，提高了檢測效率，進一步加速了市場成長。此外，免疫組化技術在藥物研發和檢測中的應用日益廣泛，開闢了新的途徑，並推動了市場擴張。同時，影像技術的快速發展提高了免疫組化技術的性能，也促進了市場成長。此外，日本醫療費用支出的不斷成長，使得先進診斷技術得以應用，這也推動了該國整體市場的成長。

本報告解答的關鍵問題：

日本免疫組織化學市場目前發展狀況如何？未來幾年又將如何發展？
新冠疫情對日本免疫組織化學市場產生了哪些影響？
日本免疫組化市場的產品組成是什麼？
日本免疫組織化學市場按應用領域分類的市場區隔如何？
日本免疫組織化學市場以最終用戶分類的市場組成是什麼？
日本免疫組織化學市場價值鏈的不同階段有哪些？
日本免疫組織化學市場的主要促進因素和挑戰是什麼？
日本免疫組織化學市場的結構是怎麼樣的？主要參與者有哪些？
日本免疫組織化學市場的競爭程度如何？

Japan immunohistochemistry market size reached USD 188.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 322.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.15% during 2026-2034. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

Antibodies
- Primary Antibodies
- Secondary Antibodies
Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
Reagents
- Histological Stains
- Blocking sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
Kits

Application Insights:

Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
Drug Testing

End User Insights:

Hospitals and Diagnostic Laboratories
Research Institutes
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan immunohistochemistry market?
What is the breakup of the Japan immunohistochemistry market on the basis of product?
What is the breakup of the Japan immunohistochemistry market on the basis of application?
What is the breakup of the Japan immunohistochemistry market on the basis of end user?
What are the various stages in the value chain of the Japan immunohistochemistry market?
What are the key driving factors and challenges in the Japan immunohistochemistry?
What is the structure of the Japan immunohistochemistry market and who are the key players?
What is the degree of competition in the Japan immunohistochemistry market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Immunohistochemistry Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Primary Antibodies
  - 6.1.3.2 Secondary Antibodies
- 6.1.4 Market Forecast (2026-2034)
6.2 Equipment
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Slide Staining Systems
  - 6.2.3.2 Tissue Microarrays
  - 6.2.3.3 Tissue Processing Systems
  - 6.2.3.4 Slide Scanners
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2026-2034)
6.3 Reagents
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Histological Stains
  - 6.3.3.2 Blocking sera and Reagents
  - 6.3.3.3 Chromogenic Substrates
  - 6.3.3.4 Fixation Reagents
  - 6.3.3.5 Stabilizers
  - 6.3.3.6 Organic Solvents
  - 6.3.3.7 Proteolytic Enzymes
  - 6.3.3.8 Diluents
- 6.3.4 Market Forecast (2026-2034)
6.4 Kits
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)

7 Japan Immunohistochemistry Market - Breakup by Application

7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Cancer
  - 7.1.3.2 Infectious Diseases
  - 7.1.3.3 Cardiovascular Diseases
  - 7.1.3.4 Autoimmune Diseases
  - 7.1.3.5 Diabetes Mellitus
  - 7.1.3.6 Nephrological Diseases
- 7.1.4 Market Forecast (2026-2034)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Immunohistochemistry Market - Breakup by End User

8.1 Hospitals and Diagnostic Laboratories
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Others
- 8.3.1 Historical and Current Market Trends (2020-2025)
- 8.3.2 Market Forecast (2026-2034)

9 Japan Immunohistochemistry Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Immunohistochemistry Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Immunohistochemistry Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis